Maravai LifeSciences Holdings 관리
관리 기준 확인 4/4
Maravai LifeSciences Holdings CEO는 Trey Martin, Jul2023 에 임명되었습니다 의 임기는 1.33 년입니다. 총 연간 보상은 $ 2.30M, 32.6% 로 구성됩니다. 32.6% 급여 및 67.4% 보너스(회사 주식 및 옵션 포함). 는 $ 1.44M 가치에 해당하는 회사 주식의 0.11% 직접 소유합니다. 1.44M. 경영진과 이사회의 평균 재임 기간은 각각 2.4 년과 4 년입니다.
주요 정보
Trey Martin
최고 경영자
US$2.3m
총 보상
| CEO 급여 비율 | 32.6% |
| CEO 임기 | 1.3yrs |
| CEO 소유권 | 0.1% |
| 경영진 평균 재임 기간 | 2.4yrs |
| 이사회 평균 재임 기간 | 4yrs |
최근 관리 업데이트
Recent updates
Slammed 37% Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Screens Well Here But There Might Be A Catch
Nov 11
Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?
Oct 15Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 29% Jump Shows Its Popularity With Investors
Jul 18Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?
Jul 15Maravai: Embedded Expectations Remain Too High Considering Economic Calculus
Jul 12RGA Investment Advisors - Maravai: Two Elite Assets With Other-Worldly Margins Wrapped In One
Jun 12Revenues Tell The Story For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) As Its Stock Soars 25%
May 14An Intrinsic Calculation For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Suggests It's 23% Undervalued
Apr 07Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable
Feb 28Revenues Working Against Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price
Dec 19Need To Know: Analysts Just Made A Substantial Cut To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Estimates
Aug 14Are Investors Undervaluing Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) By 27%?
Feb 28Is Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 01Maravai Lifesciences temporarily reinstates Carl Hull as CEO
Oct 19Maravai LifeSciences appoints former Danaher executive as CEO
Oct 03Maravai LifeSciences Holdings GAAP EPS of $0.53 beats by $0.15, revenue of $242.73M beats by $9.51M
Aug 04Estimating The Intrinsic Value Of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Jun 27Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 29CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$225m |
| Jun 30 2024 | n/a | n/a | -US$132m |
| Mar 31 2024 | n/a | n/a | -US$131m |
| Dec 31 2023 | US$2m | US$750k | -US$119m |
| Sep 30 2023 | n/a | n/a | US$25m |
| Jun 30 2023 | n/a | n/a | US$75m |
| Mar 31 2023 | n/a | n/a | US$153m |
| Dec 31 2022 | US$15m | US$660k | US$220m |
보상 대 시장: Trey 의 총 보상 ($USD 2.30M ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 5.50M ).
보상과 수익: Trey 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Trey Martin (49 yo)
1.3yrs
테뉴어
US$2,301,864
보상
Mr. William E. Martin, III, also known as Trey, is Director of Maravai LifeSciences Holdings, Inc. from July 31, 2024. He was President of Biologics Safety Testing of Maravai LifeSciences Holdings, Inc. si...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 4yrs | US$5.22m | 0.19% $ 2.6m | |
| CEO & Director | 1.3yrs | US$2.30m | 0.11% $ 1.4m | |
| Executive VP & CFO | 7.5yrs | US$2.79m | 0.022% $ 292.6k | |
| Executive VP & Chief Administrative Officer | 2.4yrs | US$2.83m | 0.039% $ 520.4k | |
| Executive VP & GM of Cygnus Technologies | 7.1yrs | US$2.26m | 0.020% $ 259.2k | |
| President of Nucleic Acid Production | 1.7yrs | US$2.99m | 0.024% $ 314.1k | |
| Senior Director of Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Executive VP | 4yrs | US$701.40k | 0.018% $ 241.1k | |
| Executive VP & Chief Commercial Officer | 1.8yrs | 데이터 없음 | 0.021% $ 275.9k | |
| Chief Innovation Officer | 1.8yrs | 데이터 없음 | 데이터 없음 |
2.4yrs
평균 재임 기간
55yo
평균 연령
경험이 풍부한 관리: MRVI 의 관리팀은 경험 ( 2.4 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 4yrs | US$5.22m | 0.19% $ 2.6m | |
| CEO & Director | less than a year | US$2.30m | 0.11% $ 1.4m | |
| Independent Director | 1.3yrs | US$435.03k | 0.020% $ 261.4k | |
| Non-Independent Director | 4yrs | US$370.48k | 0.0030% $ 39.7k | |
| Non-Independent Director | 4yrs | US$367.98k | 0.0030% $ 39.7k | |
| Independent Director | 4yrs | US$360.48k | 0.022% $ 289.2k | |
| Independent Director | 4yrs | US$395.48k | 0.025% $ 335.7k | |
| Non-Independent Director | 4yrs | US$360.48k | 0.0030% $ 39.7k | |
| Non-Independent Director | 4yrs | US$360.48k | 0.0030% $ 39.7k | |
| Independent Director | 4yrs | US$367.98k | 0.015% $ 193.5k | |
| Independent Director | 4yrs | US$387.98k | 0.047% $ 614.5k |
4.0yrs
평균 재임 기간
59yo
평균 연령
경험이 풍부한 이사회: MRVI 의 이사회는 경험(평균 재직 기간 4 년)으로 간주됩니다.